Thank you ⁦@hiltzikm⁩ for citing our research onthe different types of  personas in context of the pressure the FDA is facing to upgrade the vaccines from EUA to final authorization.  Thoughtful ⁦⁦@latimes⁩ column. https://t.co/0DHIVkrVPa